Segment Disclosure

12 Months Ended

Jun. 30, 2024

Segment Reporting [Abstract]

Segment Disclosure

Note 14. Segment Disclosure

The Company has one operating and reporting segment (oncology systems group), which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients. The Company’s Chief Executive Officer, its Chief Operating Decision Maker, reviews financial information presented on a consolidated basis for purposes of making operating decisions and assessing financial performance. The Company does not assess the performance of its individual product lines on measures of profit or loss, or asset based metrics. Therefore, the information below is presented only for revenues and long‑lived tangible assets by geographic areas.

Disaggregation of Revenues

The Company disaggregates its revenues from contracts by geographic region, as the Company believes this best depicts how the nature, amount, timing and uncertainty of revenues and cash flows are affected by economic factors. The Company reports its customer revenues in four geographic regions: the Americas, EIMEA, Asia Pacific and Japan. The Americas region primarily includes the United States, Canada, and Latin America. The EIMEA region includes Europe, India, the Middle East and Africa. The Asia Pacific region consists of Asia, Australia and New Zealand.

Additionally, the Company typically recognizes revenue at a point in time for product revenue and recognizes revenue over time for service revenue. Revenues attributed to a country or region are based on the shipping addresses of the Company’s customers.

The following summarizes revenue by geographic region (in thousands):

	Years ended June 30,
	2024		2023		2022
Americas	$	90,156	$	122,335	$	126,005
EIMEA		168,611		155,879		134,640
China		103,412		75,762		86,935
Japan		55,682		61,962		53,376
Asia Pacific, excluding China		28,690		31,667		28,953
Total net revenues	$	446,551	$	447,605	$	429,909

The following summarizes countries that represent more than ten percent of the Company’s revenues (in thousands):

	Years ended June 30,
	2024			2023			2022
United States		18	%		24	%		26	%
China		23	%		17	%		20	%
Japan		12	%		14	%		12	%
Rest of world		47	%		45	%		42	%
Total net revenues		100	%		100	%		100	%

Disaggregation of long-lived assets

Information regarding geographic areas in which the Company has long-lived assets, which consists of property, plant and equipment, net, and operating lease right-of-use assets are as follows (in thousands):

	June 30, 2024		June 30, 2023
Americas	$	46,570	$	41,569
EIMEA		9,327		3,074
China		1,211		539
Japan		1,304		1,096
Asia Pacific, excluding China		135		501
Total long-lived assets	$	58,547	$	46,779

Property and equipment, net and operating lease right-of-use assets in the Americas region are located in the United States.